Related references
Note: Only part of the references are listed.Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Phosphoantigens Overcome Human TCRVγ9+ γδ Cell Immunosuppression by TGF-β: Relevance for Cancer Immunotherapy
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2010)
Phosphoantigen-activated Vγ2Vδ2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection
Guangming Gong et al.
BLOOD (2009)
Mesenchymal stem cell-like cells derived from human gastric cancer tissues
Huiling Cao et al.
CANCER LETTERS (2009)
A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
Ludovic Martinet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
CD4+ CD25high Foxp3+ regulatory T cells downregulate human Vδ2+ T-lymphocyte function triggered by anti-CD3 or phosphoantigen
C. Scott Mahan et al.
IMMUNOLOGY (2009)
Inhibition of phosphoantigen-mediated γδ T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells
Volker Kunzmann et al.
IMMUNOLOGY (2009)
Reciprocal Interactions Between Human Mesenchymal Stem Cells and gamma delta T Cells Or Invariant Natural Killer T Cells
Ignazia Prigione et al.
STEM CELLS (2009)
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
Michael A. Morse et al.
BLOOD (2008)
CD4+CD25+ Treg cells inhibit human memory γδ T cells to produce IFN-γ in response to M tuberculosis antigen ESAT-6
Li Li et al.
BLOOD (2008)
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Kiavash Movahedi et al.
BLOOD (2008)
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
B. M. Beckermann et al.
BRITISH JOURNAL OF CANCER (2008)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
Guangwen Ren et al.
CELL STEM CELL (2008)
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vγ9Vδ2 T cells from renal cell carcinoma patients
Emilie Viey et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah et al.
NATURE (2008)
The Foxp3(+) regulatory T cell: a jack of all trades, master of regulation
Qizhi Tang et al.
NATURE IMMUNOLOGY (2008)
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Ronald J. Buckanovich et al.
NATURE MEDICINE (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing
Giselle Chamberlain et al.
STEM CELLS (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo
Daniel J. Powell et al.
JOURNAL OF IMMUNOLOGY (2007)
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Ji-Yan Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells
R. M. Dwyer et al.
CLINICAL CANCER RESEARCH (2007)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Manipulating the chemokine-chemokine receptor network to treat cancer
Pier A. Ruffini et al.
CANCER (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer
Shang-rong Ye et al.
MODERN PATHOLOGY (2007)
Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells
Lata G. Menon et al.
STEM CELLS (2007)
A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct γδ and αβ T cell responses in primates
Delphine Cendron et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity
Smita Nair et al.
CANCER RESEARCH (2007)
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity
Angela Maerten et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Immunoregulatory function of mesenchymal stem cells
Antonio Uccelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells
Alma J. Nauta et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
S Komarova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
GM Spaggiari et al.
BLOOD (2006)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Potentiation of antigen-stimulated Vγ9Vδ2 T cell cytokine production by immature dendritic cells (DC) and recpirocal effect on DC maturation
MC Devilder et al.
JOURNAL OF IMMUNOLOGY (2006)
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of Ick.: Implications in Hodgkin's lymphoma
JM Chemnitz et al.
CANCER RESEARCH (2006)
Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-activated NK cells - Involvement of protein kinase A isozyme I (PKA I)
Tatiana Raskovalova et al.
IMMUNOLOGIC RESEARCH (2006)
Peripheral γδ T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma
Emilie Viey et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism?
N Rouas-Freiss et al.
CANCER RESEARCH (2005)
Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging
SC Hung et al.
CLINICAL CANCER RESEARCH (2005)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells
A Okamoto et al.
CLINICAL CANCER RESEARCH (2005)
Activation of Vγ9Vδ2 T cells by NKG2D
B Rincon-Orozco et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gamma delta T cells: role of CD86 and inflammatory cytokines
L Conti et al.
JOURNAL OF IMMUNOLOGY (2005)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Characterization of tumor reactivity of human Vγ9Vδ2 yδ T cells in vitro and in SCID mice in vivo
D Kabelitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma
ES Doubrovina et al.
JOURNAL OF IMMUNOLOGY (2003)
Modulation of tryptophan catabolism by regulatory T cells
F Fallarino et al.
NATURE IMMUNOLOGY (2003)
Flexible migration program regulates γδ T-cell involvement in humoral immunity
M Brandes et al.
BLOOD (2003)
Altered maturation of peripheral blood dendritic cells in patients with breast cancer
S Della Bella et al.
BRITISH JOURNAL OF CANCER (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites
F Dieli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide
M Krampera et al.
BLOOD (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NKCD8(+) cells and inhibit cytotoxic T cell activity through CD8 ligation
P Contini et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Soluble HLA-G molecules are increased in lymphoproliferative disorders
Y Sebti et al.
HUMAN IMMUNOLOGY (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Human γδ T cells induce dendritic cell maturation
J Ismaili et al.
CLINICAL IMMUNOLOGY (2002)
Patterns of chemokine receptor expression on peripheral blood γδ T lymphocytes:: Strong expression of CCR5 is a selective feature of Vδ2/Vγ9 γδ T cells
A Glatzel et al.
JOURNAL OF IMMUNOLOGY (2002)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
Peripheral γδ T-cell deficit in nasopharyngeal carcinoma
BJ Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Chemokines: Agents for the immunotherapy of cancer?
B Homey et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Prostaglandins as modulators of immunity
SG Harris et al.
TRENDS IN IMMUNOLOGY (2002)
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
WP Zou et al.
NATURE MEDICINE (2001)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function
H Das et al.
IMMUNITY (2001)
Gamma/delta T cells provide innate immunity against renal cell carcinoma
H Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor
T Vang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
HLA-G suppresses proliferation of CD4+ T-lymphocytes
DRJ Bainbridge et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2000)
Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8
S Fournel et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
